Twist Bioscience posts record fiscal 2026 revenue, guides to $550M-$560M for fiscal 2027
Twist reported 22% annual revenue growth and positive fourth-quarter adjusted EBITDA, and forecast about 21% revenue growth at the midpoint for fiscal 2027.
SEC filing